119 related articles for article (PubMed ID: 1362587)
1. Neurochemical abnormalities in Huntington's disease: neurotoxic mechanisms and neurotransmitter changes.
Reynolds GP; Pearson SJ
J Neurol Sci; 1992 Dec; 113(2):230-3. PubMed ID: 1362587
[No Abstract] [Full Text] [Related]
2. Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease.
Pearson SJ; Reynolds GP
Neuropharmacology; 1988 Jul; 27(7):717-9. PubMed ID: 2901681
[TBL] [Abstract][Full Text] [Related]
3. Increase in kynurenic acid in Huntington's disease motor cortex.
Connick JH; Carlà V; Moroni F; Stone TW
J Neurochem; 1989 Mar; 52(3):985-7. PubMed ID: 2521895
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical-clinical correlates in Huntington's disease--applications of brain banking techniques.
Reynolds GP; Pearson SJ
J Neural Transm Suppl; 1993; 39():207-14. PubMed ID: 8103075
[TBL] [Abstract][Full Text] [Related]
5. [Biochemical aspects of Huntington's disease].
Bonilla E
Acta Cient Venez; 1977; 28(6):391-7. PubMed ID: 24971
[No Abstract] [Full Text] [Related]
6. Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases.
Jauch D; Urbańska EM; Guidetti P; Bird ED; Vonsattel JP; Whetsell WO; Schwarcz R
J Neurol Sci; 1995 May; 130(1):39-47. PubMed ID: 7650530
[TBL] [Abstract][Full Text] [Related]
7. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
[No Abstract] [Full Text] [Related]
8. Increased kynurenic acid levels in Huntington's disease.
Connick JH; Stone TW; Carla V; Moroni F
Lancet; 1988 Dec; 2(8624):1373. PubMed ID: 2904097
[No Abstract] [Full Text] [Related]
9. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
10. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
[TBL] [Abstract][Full Text] [Related]
11. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid.
Beal MF; Matson WR; Swartz KJ; Gamache PH; Bird ED
J Neurochem; 1990 Oct; 55(4):1327-39. PubMed ID: 2144582
[TBL] [Abstract][Full Text] [Related]
12. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain.
Walsh FX; Bird ED; Stevens TJ
Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949
[No Abstract] [Full Text] [Related]
13. Neocortical neurotransmitter markers in Huntington's disease.
Pearson SJ; Reynolds GP
J Neural Transm Gen Sect; 1994; 98(3):197-207. PubMed ID: 7748520
[TBL] [Abstract][Full Text] [Related]
14. Possible pathogenesis of Huntington's chorea and a new approach to treatment.
Divac I
Acta Neurol Scand; 1977 Oct; 56(4):357-60. PubMed ID: 21507
[TBL] [Abstract][Full Text] [Related]
15. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.
Nemeroff CB; Youngblood WW; Manberg PJ; Prange AJ; Kizer JS
Science; 1983 Sep; 221(4614):972-5. PubMed ID: 6136092
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitters and neurodegenerative disorders.
Kanazawa I
Clin Ther; 1984; 7 Spec No():48-58. PubMed ID: 6152198
[TBL] [Abstract][Full Text] [Related]
17. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
[TBL] [Abstract][Full Text] [Related]
18. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
19. Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice.
Guidetti P; Bates GP; Graham RK; Hayden MR; Leavitt BR; MacDonald ME; Slow EJ; Wheeler VC; Woodman B; Schwarcz R
Neurobiol Dis; 2006 Jul; 23(1):190-7. PubMed ID: 16697652
[TBL] [Abstract][Full Text] [Related]
20. Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex.
Reynolds GP; Pearson SJ; Heathfield KW
Neurosci Lett; 1990 May; 113(1):95-100. PubMed ID: 1973277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
